Back to news

HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells

Globe Newswire08/09/202612:50
0
Whiz Insights
No content available.